Mural Oncology plc (MURA)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Ms. Caroline J. Loew Ph.D. | President, CEO & Director | 1.01M | -- | 1971 |
| Mr. Adam D. Cutler B.A. | CFO, Principal Financial Officer & Principal Accounting Officer | 735.25k | -- | 1975 |
| Dr. Vicki L. Goodman M.D. | Chief Medical Officer | 987.25k | -- | 1971 |
| Ms. Maiken Keson-Brookes | Chief Legal Officer | -- | -- | 1973 |
| Mr. Justin Levine | Head of Human Resources & VP of Human Resources | -- | -- | -- |
Mural Oncology plc
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 116
Description
Mural Oncology plc operates as a clinical-stage oncology company that focuses on discovering and developing immunotherapies for the treatment of patients with cancer. The company's lead product candidate includes nemvaleukin alfa for the treatment of mucosal melanoma as a monotherapy and platinum-resistant ovarian cancer in combination with pembrolizumab. It also develops nemvaleukin to treat cutaneous melanoma and advanced solid tumors. The company also develops engineered interleukin-18 and tumor-targeted interleukin-12 programs. Mural Oncology plc was incorporated in 2017 and is based in Dublin, Ireland.
Corporate Governance
Upcoming Events
Upcoming Events Information Not Available
Recent Events
November 15, 2024 at 12:00 AM UTC
CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission